The Role of Activin Receptor-Like Kinase 1 Signaling in the Pulmonary Vasculature of Experimental Diaphragmatic Hernia

Abstract

Aim The high morbidity and mortality in newborn infants diagnosed with congenital diaphragmatic hernia (CDH) is widely recognized to be due to pulmonary hypoplasia and persistent pulmonary hypertension (PH). The underlying structural and molecular pathomechanisms causing PH are not fully understood. Recently, activin receptor-like kinase 1 (ALK-1), an endothelial cell (EC) receptor, has been implicated in the pathogenesis of PH. ALK-1 transmits signals via a Smad pathway stimulating EC proliferation and migration leading to structural lung remodeling consecutively resulting in PH. Increased pulmonary expression of ALK-1 has been reported in patients with severe PH as well as in experimental models of PH. We designed this study to investigate the hypothesis that pulmonary ALK-1 expression is increased in nitrofen-induced CDH.

Methods Pregnant rats were exposed to nitrofen or vehicle on D9. Fetuses were sacrificed on D21 and divided into nitrofen (n = 16) and control group (n = 16). Quantitative real-time polymerase chain reaction, Western blotting, and confocal-immunofluorescence microscopy were performed to determine pulmonary gene and protein expression as well as vascular localization of expressed ALK-1.

Results Pulmonary gene expression levels of ALK-1 were significantly upregulated in nitrofen-treated lung tissue compared with controls. Western blotting showed increased pulmonary protein expression for ALK-1 in the CDH group when compared with control lung tissue. Confocal microscopy demonstrated markedly increased medial and adventitial thickness of pulmonary arteries in the CDH group and revealed increased ALK-1 protein expression of the pulmonary vasculature of CDH pups compared with controls.

Conclusion Upregulated gene and increased protein expression of ALK-1 in the pulmonary vasculature of nitrofen-induced CDH suggest that increased expression of ALK-1 may play a crucial role in the molecular pathogenesis of vascular remodeling induced PH in experimental CDH.

Keywords

CDH - nitrofen - activin receptor-like kinase 1 - pulmonary hypertension - vascular remodeling

• References

• 1 Keijzer R, Puri P. Congenital diaphragmatic hernia. Semin Pediatr Surg 2010; 19 (3) 180-185
• 2 Christou H, Reslan OM, Mam V , et al. Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2012; 302 (9) L875-L890
• 3 Hofmann AD, Friedmacher F, Takahashi T, Gosemann JH, Puri P. Increased pulmonary vascular expression of receptor for advanced glycation end products (RAGE) in experimental congenital diaphragmatic hernia. J Pediatr Surg 2015; 50 (5) 746-749
• 4 Panchenko MP, Williams MC, Brody JS, Yu Q. Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels. Am J Physiol 1996; 270 (4 Pt 1): L547-L558
• 5 Mata-Greenwood E, Meyrick B, Steinhorn RH, Fineman JR, Black SM. Alterations in TGF-β1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2003; 285 (1) L209-L221
• 6 Jerkic M, Kabir MG, Davies A , et al. Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress. Cardiovasc Res 2011; 92 (3) 375-384
• 7 Seki T, Yun J, Oh SP. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 2003; 93 (7) 682-689
• 8 Torsney E, Charlton R, Parums D, Collis M, Arthur HM. Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res 2002; 51 (9) 464-470
• 9 van Laake LW, van den Driesche S, Post S , et al. Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 2006; 114 (21) 2288-2297
• 10 González-Núñez M, Muñoz-Félix JM, López-Novoa JM. The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?. Biochim Biophys Acta 2013; 1832 (10) 1492-1510
• 11 Hofmann AD, Takahashi T, Duess J, Gosemann JH, Puri P. Increased expression of activated pSTAT3 and PIM-1 in the pulmonary vasculature of experimental congenital diaphragmatic hernia. J Pediatr Surg 2015; 50 (6) 908-911
• 12 Wiercinska E, Wickert L, Denecke B , et al. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology 2006; 43 (5) 1032-1041
• 13 Hofmann AD, Friedmacher F, Takahashi H, Hunziker M, Gosemann JH, Puri P. Decreased apelin and apelin-receptor expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia. Pediatr Surg Int 2014; 30 (2) 197-203
• 14 Andersen CU, Hilberg O, Mellemkjær S, Nielsen-Kudsk JE, Simonsen U. Apelin and pulmonary hypertension. Pulm Circ 2011; 1 (3) 334-346
• 15 Ma L, Chung WK. The genetic basis of pulmonary arterial hypertension. Hum Genet 2014; 133 (5) 471-479
• 16 Gurbanov E, Shiliang X. The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension. Eur J Cardiothorac Surg 2006; 30 (3) 499-507
• 17 Gosemann J-H, Friedmacher F, Fujiwara N, Alvarez LA, Corcionivoschi N, Puri P. Disruption of the bone morphogenetic protein receptor 2 pathway in nitrofen-induced congenital diaphragmatic hernia. Birth Defects Res B Dev Reprod Toxicol 2013; 98 (4) 304-309
• 18 Crossno Jr JT, Garat CV, Reusch JEB , et al. Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling. Am J Physiol Lung Cell Mol Physiol 2007; 292 (4) L885-L897
• 19 Guilluy C, Sauzeau V, Rolli-Derkinderen M , et al. Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension. Br J Pharmacol 2005; 146 (7) 1010-1018
• 20 Laudi S, Trump S, Schmitz V , et al. Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin. Am J Physiol Lung Cell Mol Physiol 2007; 293 (3) L630-L638
• 21 Schermuly RT, Dony E, Ghofrani HA , et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005; 115 (10) 2811-2821
• 22 Shi Y, Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113 (6) 685-700
• 23 Harrison RE, Flanagan JA, Sankelo M , et al. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet 2003; 40 (12) 865-871
• 24 Gore B, Izikki M, Mercier O , et al. Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension. PLoS ONE 2014; 9 (6) e100310
• 25 Ramos MF, Lamé MW, Segall HJ, Wilson DW. Smad signaling in the rat model of monocrotaline pulmonary hypertension. Toxicol Pathol 2008; 36 (2) 311-320
• 26 Zhao YY, Zhao YD, Mirza MK , et al. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest 2009; 119 (7) 2009-2018
• 27 Maniatis NA, Shinin V, Schraufnagel DE , et al. Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1-/- mice. Am J Physiol Lung Cell Mol Physiol 2008; 294 (5) L865-L873
• 28 Ryter SW, Choi AMK. Caveolin-1: a critical regulator of pulmonary vascular architecture and nitric oxide bioavailability in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2008; 294 (5) L862-L864
• 29 Hofmann A, Gosemann J-H, Takahashi T, Friedmacher F, Duess JW, Puri P. Imbalance of caveolin-1 and eNOS expression in the pulmonary vasculature of experimental diaphragmatic hernia. Birth Defects Res B Dev Reprod Toxicol 2014; 101 (4) 341-346
• 30 Dingemann J, Doi T, Ruttenstock E, Puri P. Abnormal platelet-derived growth factor signaling accounting for lung hypoplasia in experimental congenital diaphragmatic hernia. J Pediatr Surg 2010; 45 (10) 1989-1994
• 31 Gosemann J-H, Friedmacher F, Hunziker M, Alvarez L, Corcionivoschi N, Puri P. Increased activation of NADPH oxidase 4 in the pulmonary vasculature in experimental diaphra gmatic hernia. Pediatr Surg Int 2013; 29 (1) 3-8
• 32 Xu S, Touyz RM. Reactive oxygen species and vascular remodelling in hypertension: still alive. Can J Cardiol 2006; 22 (11) 947-951
• 33 Meloche J, Courchesne A, Barrier M , et al. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology. J Am Heart Assoc 2013; 2 (1) e005157-e005157
• 34 Waksman JC. Cardiovascular risk of rosiglitazone: another perspective. J Pharm Pharmacol 2008; 60 (12) 1573-1582
• 35 Cunha SI, Pietras K. ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood 2011; 117 (26) 6999-7006
• 36 Cunha SI, Pardali E, Thorikay M , et al. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis. J Exp Med 2010; 207 (1) 85-100